Sulforaphane Suppresses Metastasis of Triple-Negative Breast Cancer Cells by Targeting the RAF/MEK/ERK Pathway

Investigators showed that sulforaphane (SFN), including its two isomers of R-SFN and S-SFN, significantly inhibited transforming growth factor-β1-induced migration and invasion in breast cancer cells.